Combined	combined	O	O	O	O
effects	effects	O	O	O	O
of	of	O	O	O	O
prolonged	prolonged	O	O	O	O
prostaglandin	prostaglandin	O	O	OTHERS	I
E1-induced	e1-induced	O	O	O	O
hypotension	hypotension	O	DISEASE	OTHERS	I
and	and	O	O	O	O
haemodilution	haemodilution	O	DISEASE	OTHERS	I
on	on	O	O	O	O
human	human	O	O	O	O
hepatic	hepatic	O	O	O	O
function	function	O	O	O	O
.	.	O	O	O	O

Combined	combined	O	O	O	O
effects	effects	O	O	O	O
of	of	O	O	O	O
prolonged	prolonged	O	O	O	O
prostaglandin	prostaglandin	CHEMICALS	O	OTHERS	I
E1	e1	CHEMICALS	O	OTHERS	I
(PGE1)-induced	(pge1)-induced	O	O	O	O
hypotension	hypotension	O	DISEASE	OTHERS	I
and	and	O	O	O	O
haemodilution	haemodilution	O	DISEASE	OTHERS	I
on	on	O	O	O	O
hepatic	hepatic	O	O	O	O
function	function	O	O	O	O
were	were	O	O	O	O
studied	studied	O	O	O	O
in	in	O	O	O	O
30	30	O	O	O	O
patients	patients	O	O	O	O
undergoing	undergoing	O	O	O	O
hip	hip	O	O	O	O
surgery	surgery	O	O	O	O
.	.	O	O	O	O

The	the	O	O	O	O
patients	patients	O	O	O	O
were	were	O	O	O	O
randomly	randomly	O	O	O	O
allocated	allocated	O	O	O	O
to	to	O	O	O	O
one	one	O	O	O	O
of	of	O	O	O	O
three	three	O	O	O	O
groups	groups	O	O	O	O
;	;	O	O	O	O
those	those	O	O	O	O
in	in	O	O	O	O
group	group	O	O	O	O
A	a	O	O	O	O
(	(	O	O	O	O
n	n	O	O	OTHERS	I
=	=	O	O	O	O
10	10	O	O	O	O
)	)	O	O	O	O
were	were	O	O	O	O
subjected	subjected	O	O	O	O
to	to	O	O	O	O
controlled	controlled	O	O	O	O
hypotension	hypotension	O	DISEASE	OTHERS	I
alone	alone	O	O	O	O
,	,	O	O	O	O
those	those	O	O	O	O
in	in	O	O	O	O
group	group	O	O	O	O
B	b	O	O	O	O
(	(	O	O	O	O
n	n	O	O	OTHERS	I
=	=	O	O	O	O
10	10	O	O	O	O
)	)	O	O	O	O
to	to	O	O	O	O
haemodilution	haemodilution	O	DISEASE	OTHERS	I
alone	alone	O	O	O	O
and	and	O	O	O	O
those	those	O	O	O	O
in	in	O	O	O	O
group	group	O	O	O	O
C	c	O	O	OTHERS	I
(	(	O	O	O	O
n	n	O	O	OTHERS	I
=	=	O	O	O	O
10	10	O	O	O	O
)	)	O	O	O	O
to	to	O	O	O	O
both	both	O	O	O	O
controlled	controlled	O	O	O	O
hypotension	hypotension	O	DISEASE	OTHERS	I
and	and	O	O	O	O
haemodilution	haemodilution	O	DISEASE	OTHERS	I
.	.	O	O	O	O

Haemodilution	haemodilution	O	DISEASE	OTHERS	I
in	in	O	O	O	O
groups	groups	O	O	O	O
B	b	O	O	O	O
and	and	O	O	O	O
C	c	O	O	OTHERS	I
was	was	O	O	O	O
produced	produced	O	O	O	O
by	by	O	O	O	O
withdrawing	withdrawing	O	O	O	O
approximately	approximately	O	O	O	O
1000	1000	O	O	O	O
mL	ml	O	O	O	O
of	of	O	O	O	O
blood	blood	O	O	O	O
and	and	O	O	O	O
replacing	replacing	O	O	O	O
it	it	O	O	O	O
with	with	O	O	O	O
the	the	O	O	O	O
same	same	O	O	O	O
amount	amount	O	O	O	O
of	of	O	O	O	O
dextran	dextran	CHEMICALS	O	OTHERS	I
solution	solution	O	O	O	O
,	,	O	O	O	O
and	and	O	O	O	O
final	final	O	O	O	O
haematocrit	haematocrit	O	O	O	O
values	values	O	O	O	O
were	were	O	O	O	O
21	21	O	O	O	O
or	or	O	O	O	O
22	22	O	O	O	O
%	%	O	O	O	O
.	.	O	O	O	O

Controlled	controlled	O	O	O	O
hypotension	hypotension	O	DISEASE	OTHERS	I
in	in	O	O	O	O
groups	groups	O	O	O	O
A	a	O	O	O	O
and	and	O	O	O	O
C	c	O	O	OTHERS	I
was	was	O	O	O	O
induced	induced	O	O	O	O
with	with	O	O	O	O
PGE1	pge1	CHEMICALS	O	OTHERS	I
to	to	O	O	O	O
maintain	maintain	O	O	O	O
mean	mean	O	O	O	O
arterial	arterial	O	O	O	O
blood	blood	O	O	O	O
pressure	pressure	O	O	O	O
at	at	O	O	O	O
55	55	O	O	O	O
mmHg	mmhg	O	O	O	O
for	for	O	O	O	O
180	180	O	O	O	O
min	min	O	O	O	O
.	.	O	O	O	O

Measurements	measurements	O	O	O	O
included	included	O	O	O	O
arterial	arterial	O	O	O	O
ketone	ketone	O	O	OTHERS	I
body	body	O	O	O	O
ratio	ratio	O	O	O	O
(	(	O	O	O	O
AKBR	akbr	O	O	O	O
,	,	O	O	O	O
aceto-acetate/3-hydroxybutyrate	aceto-acetate/3-hydroxybutyrate	O	O	O	O
)	)	O	O	O	O
and	and	O	O	O	O
clinical	clinical	O	O	O	O
hepatic	hepatic	O	O	O	O
function	function	O	O	O	O
parameters	parameters	O	O	O	O
.	.	O	O	O	O

AKBR	akbr	O	O	O	O
and	and	O	O	O	O
biological	biological	O	O	O	O
hepatic	hepatic	O	O	O	O
function	function	O	O	O	O
tests	tests	O	O	O	O
showed	showed	O	O	O	O
no	no	O	O	O	O
change	change	O	O	O	O
throughout	throughout	O	O	O	O
the	the	O	O	O	O
time	time	O	O	O	O
course	course	O	O	O	O
in	in	O	O	O	O
groups	groups	O	O	O	O
A	a	O	O	O	O
and	and	O	O	O	O
B.	b.	O	O	O	O
In	in	O	O	O	O
group	group	O	O	O	O
C	c	O	O	OTHERS	I
,	,	O	O	O	O
AKBR	akbr	O	O	O	O
showed	showed	O	O	O	O
a	a	O	O	O	O
significant	significant	O	O	O	O
decrease	decrease	O	O	O	O
at	at	O	O	O	O
120	120	O	O	O	O
min	min	O	O	O	O
(	(	O	O	O	O
-40	-40	O	O	O	O
%	%	O	O	O	O
)	)	O	O	O	O
and	and	O	O	O	O
at	at	O	O	O	O
180	180	O	O	O	O
min	min	O	O	O	O
(	(	O	O	O	O
-49	-49	O	O	O	O
%	%	O	O	O	O
)	)	O	O	O	O
after	after	O	O	O	O
the	the	O	O	O	O
start	start	O	O	O	O
of	of	O	O	O	O
hypotension	hypotension	O	DISEASE	OTHERS	I
and	and	O	O	O	O
at	at	O	O	O	O
60	60	O	O	O	O
min	min	O	O	O	O
(	(	O	O	O	O
-32	-32	O	O	O	O
%	%	O	O	O	O
)	)	O	O	O	O
after	after	O	O	O	O
recovery	recovery	O	O	O	O
of	of	O	O	O	O
normotension	normotension	O	O	O	O
,	,	O	O	O	O
and	and	O	O	O	O
SGOT	sgot	O	O	O	O
,	,	O	O	O	O
SGPT	sgpt	O	O	O	O
,	,	O	O	O	O
LDH	ldh	O	O	O	O
and	and	O	O	O	O
total	total	O	O	O	O
bilirubin	bilirubin	CHEMICALS	O	OTHERS	I
showed	showed	O	O	O	O
significant	significant	O	O	O	O
increases	increases	O	O	O	O
after	after	O	O	O	O
operation	operation	O	O	O	O
.	.	O	O	O	O

The	the	O	O	O	O
results	results	O	O	O	O
suggest	suggest	O	O	O	O
that	that	O	O	O	O
a	a	O	O	O	O
prolonged	prolonged	O	O	O	O
combination	combination	O	O	O	O
of	of	O	O	O	O
more	more	O	O	O	O
than	than	O	O	O	O
120	120	O	O	O	O
min	min	O	O	O	O
of	of	O	O	O	O
PGE1-induced	pge1-induced	O	O	O	O
hypotension	hypotension	O	DISEASE	OTHERS	I
and	and	O	O	O	O
moderate	moderate	O	O	O	O
haemodilution	haemodilution	O	DISEASE	OTHERS	I
would	would	O	O	O	O
cause	cause	O	O	O	O
impairment	impairment	O	O	OTHERS	I
of	of	O	O	OTHERS	I
hepatic	hepatic	O	O	OTHERS	I
function	function	O	O	OTHERS	I
.	.	O	O	O	O

